WGb-0301 Injection
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for WGb-0301 Injection, covering 2026-01-12 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection [EARLY_Phase 1]